Abstract:BACKGROUND: The spared nerve injury (SNI) model is a new animal model that can mimic several characteristics of clinical neuropathic pain. Opioids are recommended as treatment of neuropathic pain. Therefore, the present study was conducted to investigate the antinociceptive effects of endomorphin-1 (EM-1) and endomorphin-2 (EM-2) given centrally and peripherally in the SNI model of neuropathic pain in mice. METHODS: The SNI model was made in mice by sparing the sural nerve intact, when the other 2 of 3 terminal branches of the sciatic nerve (common peroneal and tibial nerves) were tightly ligated and cut. Von Frey monofilaments were used to measure the SNI-induced mechanical allodynia-like behavior. The antiallodynic effects of EM-1 and EM-2 were determined after central and peripheral administration in the SNI model of neuropathic pain. Also, the specific opioid receptor antagonists were used to determine the opioid mechanisms of EMs involved in neuropathic pain. Values were expressed as the mean ± standard deviation. RESULTS: Our results showed that the SNI mice developed prolonged mechanical allodynia-like behavior in ipsilateral paw after surgery, with the withdrawal threshold value being 0.061 ± 0.02 g after 14 days. EM-1 and EM-2 produced significant antiallodynic effects in ipsilateral paw after intracerebroventricular (i.c.v.) administration, more effective than that of morphine. The peak withdrawal thresholds of 10 nmol EM-1 and EM-2 determined at 5 minutes after injection were 0.92 ± 0.36 and 0.87 ± 0.33 g, respectively, higher than that of morphine (0.46 ± 0.20 g). Moreover, both EMs (10 nmol, i.c.v.) exerted significant antiallodynic effects in the contralateral paw, whereas no significant antinociceptive activity was seen after i.c.v. administration of morphine with equimolar dose. It was noteworthy that EM-1 and EM-2 produced antinociception through distinct μ1- and μ2-opioid receptor subtypes, and the EM-2-induced antiallodynia contained an additional component that was mediated by the release of endogenous dynorphin A, acting on κ-opioid receptor. In addition, the antiallodynic activities of peripheral administration of EM-1, EM-2, and morphine were also investigated. Intraplantar, but not subcutaneous administration of EM-1 and EM-2 also exhibited potent antinociception, establishing the peripheral and local effects. Both μ1- and μ2-opioid receptor subtypes, but not the δ- or κ-opioid receptors were involved in the peripheral antiallodynia of EMs. CONCLUSIONS: The present investigation demonstrated that both EM-1 and EM-2 given centrally and peripherally produced potent antiallodynic activities in SNI mice, and differential opioid mechanisms were involved.

Endomorphin 1‐ and Endomorphin 2‐containing Neurons in Nucleus Tractus Solitarii Send Axons to the Parabrachial Nuclei in the Rat

Topographical Distributions of Endomorphinergic Pathways from Nucleus Tractus Solitarii to Periaqueductal Gray in the Rat

Morphological evidence for endomorphine 2 and μ opioid receptor involved in modulation of visceral sensation and movement in the rat

Morphological features of endomorphin-2-immunoreactive ultrastructures in the dorsal root ganglion and spinal dorsal horn of the rat

Mechanism Underlying the Analgesic Effect Exerted by Endomorphin-1 in the Rat Ventrolateral Periaqueductal Gray

Changes in brain content of nociceptin/orphanin FQ and endomorphin 2 in a rat model of neuropathic pain

In vitro characterization of the effects of endomorphin 1 and 2, endogenous ligands for mu-opioid receptors, on mouse colonic motility.

Antiallodynic Effects of Endomorphin-1 and Endomorphin-2 in the Spared Nerve Injury Model of Neuropathic Pain in Mice

Retraction Notice to "antinociceptive Effects of Endomorphin-2: Suppression of Substance P Release in the Inflammatory Pain Model Rat".

Central afferents to the nucleus of the solitary tract in rats and mice

Glutamatergic Lateral Parabrachial Neurons Innervate Orexin-Containing Hypothalamic Neurons in the Rat.

Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics

The Spinal Antinociceptive Effects of Endomorphins in Rats: Behavioral and G Protein Functional Studies

Mesencephalic Dopaminergic Neurons Expressing Neuromedin K Receptor (NK3): a Double Immunocytochemical Study in the Rat

Calbindin D28k-containing neurons in the paratrigeminal nucleus receive convergent nociceptive information and project to nucleus of the solitary tract in rat.

Co-localization of Μ-Opioid Receptor-Like Immunoreactivity with Substance P-LI, Calcitonin Gene-Related Peptide-Li and Nitric Oxide Synthase-Li in Vagal and Glossopharyngeal Afferent Neurons of the Rat

Endomorphin 1[psi] and Endomorphin 2[psi], Endomorphins Analogues Containing A Reduced (ch2nh) Amide Bond Between Tyr(1) and Pro(2), Display Partial Agonist Potency but Significant Antinociception

Immunocytochemical localization of μ-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat

Substance P Receptor-Expressing Neurons in the Medullary and Spinal Dorsal Horns Projecting to the Nucleus of the Solitary Tract in the Rat

333 Immunohistochemical Localization of Mu Opioid Receptors in the Central Nervous System of the Rat

Divergent neural pathways emanating from the lateral parabrachial nucleus mediate distinct components of the pain response